UB Paderborn / Katalog / Suche / in CDI

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism

International journal of molecular sciences, 2023-02, Vol.24 (3), p.3037

2023

Link zum Volltext

Verfügbarkeit prüfen

High Ferritin Is Not Needed in Hemodialysis Patients: A Retrospective Study of Total Body Iron and Oral Iron Replacement Therapy

International journal of molecular sciences, 2024-02, Vol.25 (3), p.1508

2024

Link zum Volltext

Verfügbarkeit prüfen

A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis Patients

International journal of molecular sciences, 2020-10, Vol.21 (19), p.7153

2020

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia-inducible factor prolyl hydroxylase domain inhibitor may maintain hemoglobin synthesis at lower serum ferritin and transferrin saturation levels than darbepoetin alfa

PloS one, 2021-06, Vol.16 (6), p.e0252439-e0252439

2021

Link zum Volltext

Verfügbarkeit prüfen

High serum magnesium levels are associated with favorable prognoses in diabetic hemodialysis patients, retrospective observational study

PloS one, 2020-09, Vol.15 (9), p.e0238763-e0238763

2020

Link zum Volltext

Verfügbarkeit prüfen

Low-Dose Oral Iron Replacement Therapy Is Effective for Many Japanese Hemodialysis Patients: A Retrospective Observational Study

Nutrients, 2022-12, Vol.15 (1), p.125

2022

Link zum Volltext

Verfügbarkeit prüfen

Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study

PloS one, 2017-06, Vol.12 (6), p.e0179608-e0179608

2017

Link zum Volltext

Verfügbarkeit prüfen

Oral Iron Absorption of Ferric Citrate Hydrate and Hepcidin-25 in Hemodialysis Patients: A Prospective, Multicenter, Observational Riona-Oral Iron Absorption Trial

International journal of molecular sciences, 2023-09, Vol.24 (18), p.13779

2023

Link zum Volltext

Verfügbarkeit prüfen

Multicenter laparoscopic evaluation of the peritoneum in peritoneal dialysis patients

Seminars in dialysis, 2020-03, Vol.33 (2), p.170-177

2020

Link zum Volltext

Verfügbarkeit prüfen

Reticulocyte hemoglobin content

Clinica chimica acta, 2020-05, Vol.504, p.138-145

2020

Link zum Volltext

Verfügbarkeit prüfen

P1598USE EXPERIENCE OF FIRAPY (FAR-INFRARED THERAPY) TREATMENT FOR WOUND OF HEMODIALYSIS PATIENTS

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Link zum Volltext

Verfügbarkeit prüfen

Influence of proton pump inhibitors and histamine H2 receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review

Journal of pharmaceutical health care and sciences, 2016-11, Vol.2 (1), p.34-34, Article 34

2016

Link zum Volltext

Verfügbarkeit prüfen

Threshold of Serum Ferritin to Discriminate against Those at Greater Risk of Platelet Increase during Treatment with Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitor

Acta haematologica, 2022-01, Vol.145 (4), p.412-418

2022

Link zum Volltext

Verfügbarkeit prüfen

SP369THE TARGET HB CONTENT OF RETICULOCYTE (CHR) VALUE FOR EFFICIENT ANEMIA IMPROVEMENT ON HEMODIALYSIS PATIENTS TREATED WITH DARBEPOETIN ALFA IS ACHIEVED BY LOW FERRITIN LEVEL AND MODERATE TRANSFERRIN SATURATION

Nephrology, dialysis, transplantation, 2019-06, Vol.34 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Heparin-Related Thrombocytopenia Triggered by Severe Status of Systemic Lupus Erythematosus and Bacterial Infection

Case reports in rheumatology, 2016-01, Vol.2016, p.6571621-5

2016

Link zum Volltext

Verfügbarkeit prüfen

SP356THE TARGET HB CONTENT OF RETICULOCYTE (CHR) VALUE FOR EFFICIENT ANEMIA IMPROVEMENT IS ACHIEVED BY LOW FERRITIN LEVEL AND MODERATE TRANSFERRIN SATURATION

Nephrology, dialysis, transplantation, 2018-05, Vol.33 (suppl_1), p.i465-i466

2018

Link zum Volltext

Verfügbarkeit prüfen

MP420LOW LEVELS OF SERUM FERRITIN AND MODERATE TRANSFERRIN SATURATION LEAD TO ADEQUATE HEMOGLOBIN LEVELS IN HEMODIALYSIS PATIENTS

Nephrology, dialysis, transplantation, 2017-05, Vol.32 (suppl_3), p.iii582-iii583

2017

Link zum Volltext

Verfügbarkeit prüfen

Significance of Content of the Reticulocyte Hemoglobin in the Management of Renal Anemia

Blood purification, 2019-01, Vol.47 (Suppl 2), p.70-73

2019

Link zum Volltext

Verfügbarkeit prüfen

SP554LOW LEVELS OF SERUM FERRITIN WITH MODERATE LEVEL OF TRANSFERRIN SATURATION MAINTAINS ADEQUATE ANEMIA CONTROL IN HEMODIALYSIS PATIENTS TREATED WITH DARBEPOETIN ALFA

Nephrology, dialysis, transplantation, 2016-05, Vol.31 (suppl_1), p.i276-i277

2016

Link zum Volltext

Verfügbarkeit prüfen

FP655LOW LEVELS OF SERUM FERRITIN WITH MODERATE LEVEL OF TRANSFERRIN SATURATION MAINTAINS ADEQUATE HEMOGLOBIN IN HEMODIALYSIS PATIENTS

Nephrology, dialysis, transplantation, 2015-05, Vol.30 (suppl_3), p.iii292-iii293

2015

Link zum Volltext

Verfügbarkeit prüfen

The target hemoglobin content values of reticulocytes for efficient anemia improvement are achieved by low ferritin levels and moderate transferrin saturation: a retrospective observational study

Hematology (Luxembourg), 2020-01, Vol.25 (1), p.71-78

2020

Link zum Volltext

Verfügbarkeit prüfen

High serum magnesium levels are associated with favorable prognoses in diabetic hemodialysis patients, retrospective observational study

PloS one, 2020-01, Vol.15 (9)

2020

Link zum Volltext

Verfügbarkeit prüfen

Usefulness of a Body Composition Analyzer, InBody 2.0, in Chronic Hemodialysis Patients

The Kaohsiung journal of medical sciences, 2006-05, Vol.22 (5), p.207-210

2006

Link zum Volltext

Verfügbarkeit prüfen

HEPATITIS C VIRUS INFECTION IN HEMODIALYSIS PATIENTS: COMPARISON OF THE SURABAYA DIALYSIS CENTER AND JUNTENDO UNIVERSITY HOSPITAL DIALYSIS CENTRE

Indonesian Journal of Tropical and Infectious Disease, 2010-09, Vol.1 (3), p.105-109

2010

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism

High Ferritin Is Not Needed in Hemodialysis Patients: A Retrospective Study of Total Body Iron and Oral Iron Replacement Therapy

A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis Patients

Hypoxia-inducible factor prolyl hydroxylase domain inhibitor may maintain hemoglobin synthesis at lower serum ferritin and transferrin saturation levels than darbepoetin alfa

High serum magnesium levels are associated with favorable prognoses in diabetic hemodialysis patients, retrospective observational study

Low-Dose Oral Iron Replacement Therapy Is Effective for Many Japanese Hemodialysis Patients: A Retrospective Observational Study

Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study

Oral Iron Absorption of Ferric Citrate Hydrate and Hepcidin-25 in Hemodialysis Patients: A Prospective, Multicenter, Observational Riona-Oral Iron Absorption Trial

Multicenter laparoscopic evaluation of the peritoneum in peritoneal dialysis patients

Reticulocyte hemoglobin content

P1598USE EXPERIENCE OF FIRAPY (FAR-INFRARED THERAPY) TREATMENT FOR WOUND OF HEMODIALYSIS PATIENTS

Influence of proton pump inhibitors and histamine H2 receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review

Comparison Between the Fixation of Peritoneal Dialysis Catheters to the Peritoneal Wall and the Conventional Placement Technique: Clinical Experience and Follow-Up of a New Implant Technique for Peritoneal Dialysis Catheters

Threshold of Serum Ferritin to Discriminate against Those at Greater Risk of Platelet Increase during Treatment with Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitor

SP369THE TARGET HB CONTENT OF RETICULOCYTE (CHR) VALUE FOR EFFICIENT ANEMIA IMPROVEMENT ON HEMODIALYSIS PATIENTS TREATED WITH DARBEPOETIN ALFA IS ACHIEVED BY LOW FERRITIN LEVEL AND MODERATE TRANSFERRIN SATURATION

Heparin-Related Thrombocytopenia Triggered by Severe Status of Systemic Lupus Erythematosus and Bacterial Infection

SP356THE TARGET HB CONTENT OF RETICULOCYTE (CHR) VALUE FOR EFFICIENT ANEMIA IMPROVEMENT IS ACHIEVED BY LOW FERRITIN LEVEL AND MODERATE TRANSFERRIN SATURATION

MP420LOW LEVELS OF SERUM FERRITIN AND MODERATE TRANSFERRIN SATURATION LEAD TO ADEQUATE HEMOGLOBIN LEVELS IN HEMODIALYSIS PATIENTS

Significance of Content of the Reticulocyte Hemoglobin in the Management of Renal Anemia

SP554LOW LEVELS OF SERUM FERRITIN WITH MODERATE LEVEL OF TRANSFERRIN SATURATION MAINTAINS ADEQUATE ANEMIA CONTROL IN HEMODIALYSIS PATIENTS TREATED WITH DARBEPOETIN ALFA

FP655LOW LEVELS OF SERUM FERRITIN WITH MODERATE LEVEL OF TRANSFERRIN SATURATION MAINTAINS ADEQUATE HEMOGLOBIN IN HEMODIALYSIS PATIENTS

The target hemoglobin content values of reticulocytes for efficient anemia improvement are achieved by low ferritin levels and moderate transferrin saturation: a retrospective observational study

High serum magnesium levels are associated with favorable prognoses in diabetic hemodialysis patients, retrospective observational study

Usefulness of a Body Composition Analyzer, InBody 2.0, in Chronic Hemodialysis Patients

HEPATITIS C VIRUS INFECTION IN HEMODIALYSIS PATIENTS: COMPARISON OF THE SURABAYA DIALYSIS CENTER AND JUNTENDO UNIVERSITY HOSPITAL DIALYSIS CENTRE

Suchergebnisse filtern